Dyslipidemia In Patients Whith Rheumatoid Arthritis

Authors

  • Abdalrazak Hassan Tishreen University
  • Youssef Zreik Tishreen University
  • Lames Haidar Tishreen University

Abstract

Background: Rheumatoid arthritis is one of the most common chronic inflammatory arthritis , inflammatory process doesn´t involve only the joints  but it may include other extra articular manifestation .

Patients whith Rheumatoid arthritis have higher risk of  cardiovascular disease than others and atherosclerosis is  the most common cause of death , dyslipidemia caused by chronic inflammatory process is considered one of the most important cardiovascular risks , so this research aims to investigate dyslipidemia in these patients to reduce morbidity and mortality.

The goal of the study: to determine the frequency of dyslipidemia in patients whith Rheumatoid arthritis , evaluate the relation between lipid profile and disease activity score (DAS 28) and classification dyslipidemia according the type of treatment using in manengement Rheumatoid arthritis.

Methods: An observational cross sectional study included 80 patients fulfilling the ACR-EULAR 2010 criteria for RA . clinical assessments were performed by evaluation of disease activity score (DAS 28) and laboratory investigations of lipid profile including triglycerides (TG),total cholesterol (TC) ,low density lipoprotein (LDL)and high density lipoprotein (HDL) were performed .

Results and discussion:  the mean age was 52.9±12.4 years and the mean duration of disease was 12±8.8 years . 67.5 % of patients had dyslipidemia ,and the commonest abnormality was a low HDL ,seen in 40 % , raised TG was found in 37.5% raised TC was found in 15% and raised LDL was found in 10 % of the patients .

Dyslipidemia was found in 84% of patients under treatment whith prednisolone , 81% in patients under treatment whith prednisolone and leflonomide ,75 % in those whith no treatment ,64.3 % in patients under treatment whith  prednisolone and methotrexate and 57.1% in patients under treatment whith prednisolone and methotrexate and anti malaria. results also  show that patients under treatment whith prednisolone had higher concentrations of HDL than those not treated (p value= 0.047).

DAS 28 showed high negative correlation whith HDL(R= - 0.69),  moderately positive correlation whith TG (R= o.475),high negative correlation whith TC (R= - 0.629) and moderately negative correlation whith LDL (R= - 0.552).

Author Biographies

Abdalrazak Hassan, Tishreen University

Professor, faculty of Medicine

Youssef Zreik, Tishreen University

Assistant Professor, faculty of Medicine,

Lames Haidar, Tishreen University

Postgraduate student, faculty of Medicine

Downloads

Published

2022-06-16

How to Cite

1.
عبد الرزاق حسن, يوسف زريق, لميس حيدر. Dyslipidemia In Patients Whith Rheumatoid Arthritis. Tuj-hlth [Internet]. 2022Jun.16 [cited 2024Apr.28];44(2):407-22. Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/12692

Issue

Vol. 44 No. 2 (2022): Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

Section

Master student researches

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.